Global Opioid Use Disorder OUD Market Report 2024

Opioid Use Disorder (OUD) Global Market Report 2025 – By Drug Type (Buprenorphine, Naltrexone, Methadone), By Route of Administration (Oral, Parenteral), By Age Group (19 To 40, 41 To 60, 61 And Over), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies And Stores, Online Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

Opioid Use Disorder (OUD) Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Opioid Use Disorder (OUD) Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN

Opioid Use Disorder (OUD) Market Definition

Opioid use disorder (OUD) is a chronic brain disease resulting from prolonged use of opioids, including both prescription painkillers and illegal opioids. Opioid use disorder can develop due to genetic, environmental, and behavioral factors.

The main types of drugs for opioid use disorder (OUD) are buprenorphine, naltrexone, and methadone. Buprenorphine refers to a medication that belongs to the class of drugs known as opioids. Buprenorphine is used in the treatment of opioid use disorder (OUD) to reduce cravings and withdrawal symptoms associated with opioid dependence. They are administered through oral and parenteral routes for various age groups including 19 to 40, 41 to 60, 61 and over. It is distributed by hospital pharmacies, retail pharmacies and stores, and online pharmacies.

Opioid Use Disorder (OUD) Market Segmentation

The opioid use disorder (OUD) market covered in this report is segmented –

1) By Drug Type: Buprenorphine, Naltrexone, Methadone

2) By Route of Administration: Oral, Parenteral

3) By Age Group: 19 To 40, 41 To 60, 61 And Over

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Stores, Online Pharmacies

Subsegments:

1) By Buprenorphine: Suboxone, Buprenorphine Tablets, Buprenorphine Film

2) By Naltrexone: Naltrexone Tablets, Vivitrol

3) By Methadone: Methadone Tablets, Methadone Oral Solution

Opioid Use Disorder (OUD) Market Size and growth rate 2025 to 2029: Graph

Opioid Use Disorder (OUD) Market Size 2025 And Growth Rate

The opioid use disorder (OUD) market size has grown rapidly in recent years. It will grow from $3.96 billion in 2024 to $4.39 billion in 2025 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to increased prescription rates, pain management practices, drug marketing, stigmatization of addiction

Opioid Use Disorder (OUD) Market Growth Forecast

The opioid use disorder (OUD) market size is expected to see rapid growth in the next few years. It will grow to $6.94 billion in 2029 at a compound annual growth rate (CAGR) of 12.1%. The growth in the forecast period can be attributed to regulatory interventions, focus on alternative pain management, expansion of treatment access, public health initiatives,. Major trends in the forecast period include technological innovations in treatment, individualized treatment approaches, integrated care models, community-based support programs, early intervention and prevention.

Opioid Use Disorder (OUD) Market Driver: Growing Number Of Opioid Addiction Cases

The growing number of opioid addiction cases is expected to propel the growth of the opioid use disorder (OUD) market going forward. Opioid addiction refers to a medical condition characterized by compulsive and chronic opioid use that has harmful effects on the body. Opioids can produce a sense of euphoria and pain relief, whose continued usage can lead to the development of tolerance, where higher doses are needed to achieve the same effect, which may lead to opioid use disorder. For instance, in March 2024, according to the Centers for Disease Control and Prevention, a US-based public health agency, the rate of synthetic opioid drug overdosage rose by 4.1%, increasing from 21.8 to 22.7 between 2021 and 2022. Therefore, the growing number of opioid addiction cases drives the growth of the opioid use disorder (OUD) market.

Opioid Use Disorder (OUD) Market Driver: Rise In The Prevalence Of Chronic Disease

Rise in the prevalence of chronic disease is expected to propel the growth of the opioid use disorder (OUD) market going forward. Chronic diseases are problems that last a year or longer, necessitating continuing medical care, restricting everyday activities, or both. Many chronic conditions, such as severe pain associated with cancer, arthritis, or other long-term illnesses, often necessitate the use of opioid medications for effective pain management. For instance, in January 2023, according to the National Centre for Biotechnology Information (NCBI), a US-based National Library of Medicine, it was projected that by the year 2050, the number of individuals aged 50 years and older who have at least one chronic illness will surge by 99.5%, rising from 71.522 million in 2020 to 142.66 million. Therefore, the rise in the prevalence of chronic disease drives the growth of the opioid use disorder (OUD) market.

Global Opioid Use Disorder (OUD) Market Major Players

Major companies operating in the opioid use disorder (OUD) market include Pfizer Inc., Novartis AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Chiesi Pharmaceuticals S.p.A., Hikma Pharmaceuticals Plc., Mallinckrodt Pharmaceuticals, Indivior Plc., Purdue Pharma L.P, Alkermes Inc., Collegium Pharmaceutical Inc., Vanda Pharmaceuticals Inc., Camurus AB, Tris Pharma Inc., Mylan NV., Orexo US Inc., Zogenix Inc., Rhodes Pharmaceuticals L.P., Omeros Corporation, Braeburn Pharmaceuticals Inc., Adapt Pharma Inc., Titan Pharmaceuticals Inc., BioDelivery Sciences International Inc., AcelRx Pharmaceuticals Inc., KemPharm Inc.

Global Opioid Use Disorder (OUD) Market Trend: FDA Approval Of Brixadi Marks A Milestone In Opioid Use Disorder (OUD) Market Through Innovative Treatment Options

Product innovation is a key trend gaining popularity in the opioid use disorder (OUD) market. Major companies operating in the opioid use disorder (OUD) market are developing innovative products to sustain their position in the market. For instance, in May 2023, the U.S. Food and Drug Administration, a US-based federal agency, approved Brixadi (buprenorphine) extended-release injection to treat moderate to severe opioid use disorder (OUD). Brixadi is available in two dosage forms a weekly injection for patients who began treatment with a single dose of a transmucosal buprenorphine product or who are currently taking the medication and a monthly version for those who are already receiving the medication.

Global Opioid Use Disorder (OUD) Market Trend: Harm Reduction Therapeutics And Catalent Join Forces To Enhance Access To Opioid Overdose Treatment In The Opioid Use Disorder (OUD) Market

Major companies operating in the opioid use disorder (OUD) market are focused on forming strategic alliances to strengthen their position in the market. Strategic alliances can take various forms and are aimed at achieving mutual benefits and strengthening the position of the companies involved. For instance, in March 2023, Harm Reduction Therapeutics, a US-based non-profit pharmaceutical company, entered a partnership with Catalent, Inc., a US-based company in developing and delivering better treatments to patients around the world. Under this agreement, Catalent, Inc. will manufacture RiVive (3.0 mg), a naloxone nasal spray for harm reduction therapy for emergency treatment of known or suspected opioid overdose. The opioid epidemic is an ongoing national tragedy, and for OTC naloxone to address this unmet needed a manufacturing partner with the capability and bandwidth to help make naloxone much more widely and easily accessible to save lives that will otherwise be lost to opioid overdose.

Opioid Use Disorder (OUD) Market Merger And Acquisition: Indivior Enhances Addiction Treatment Portfolio With Acquisition Of Opiant Pharmaceuticals

In March 2023, Indivior PLC, a US-based pharmaceutical company, acquired Opiant Pharmaceuticals Inc. for $145 million. The acquisition is expected to help Indivior plc strengthen and extend its product offering for addiction treatment. Opiant Pharmaceuticals Inc. is a US-based pharmaceutical company that focuses on developing drugs for treating opioid overdose, acute cannabinoid overdose, and opioid use disorder.

Regional Outlook For The Global Opioid Use Disorder (OUD) Market

North America was the largest region in the opioid use disorder (OUD) market in 2024. The regions covered in the opioid use disorder (OUD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the opioid use disorder (OUD) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

What Defines the Opioid Use Disorder (OUD) Market?

The opioid use disorder (OUD) market consists of sales of bunavail, sublocade, suboxone, and zubsolv. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Opioid Use Disorder (OUD) Industry?

The opioid use disorder (OUD) research report is one of a series of new reports from The Business Research Company that provides opioid use disorder (OUD) market statistics, including the opioid use disorder (OUD) industry's global market size, regional shares, competitors with opioid use disorder (OUD) market share, detailed opioid use disorder (OUD) market segments, market trends and opportunities, and any further data you may need to thrive in the opioid use disorder (OUD) industry. This opioid use disorder (OUD) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Opioid Use Disorder (OUD) Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $4.39 billion
Revenue Forecast In 2034 $6.94 billion
Growth Rate CAGR of 12.1% from 2024 to 2033
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Drug Type: Buprenorphine, Naltrexone, Methadone
2) By Route of Administration: Oral, Parenteral
3) By Age Group: 19 To 40, 41 To 60, 61 And Over
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Stores, Online Pharmacies Subsegments: 1) By Buprenorphine: Suboxone, Buprenorphine Tablets, Buprenorphine Film
2) By Naltrexone: Naltrexone Tablets, Vivitrol
3) By Methadone: Methadone Tablets, Methadone Oral Solution
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Novartis AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Chiesi Pharmaceuticals S.p.A., Hikma Pharmaceuticals Plc., Mallinckrodt Pharmaceuticals, Indivior Plc., Purdue Pharma L.P, Alkermes Inc., Collegium Pharmaceutical Inc., Vanda Pharmaceuticals Inc., Camurus AB, Tris Pharma Inc., Mylan NV., Orexo US Inc., Zogenix Inc., Rhodes Pharmaceuticals L.P., Omeros Corporation, Braeburn Pharmaceuticals Inc., Adapt Pharma Inc., Titan Pharmaceuticals Inc., BioDelivery Sciences International Inc., AcelRx Pharmaceuticals Inc., KemPharm Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Opioid Use Disorder (OUD) Market Characteristics

    3. Opioid Use Disorder (OUD) Market Trends And Strategies

    4. Opioid Use Disorder (OUD) Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

    5. Global Opioid Use Disorder (OUD) Growth Analysis And Strategic Analysis Framework

    5.1. Global Opioid Use Disorder (OUD) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Opioid Use Disorder (OUD) Market Growth Rate Analysis

    5.4. Global Opioid Use Disorder (OUD) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Opioid Use Disorder (OUD) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Opioid Use Disorder (OUD) Total Addressable Market (TAM)

    6. Opioid Use Disorder (OUD) Market Segmentation

    6.1. Global Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Buprenorphine

    Naltrexone

    Methadone

    6.2. Global Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Oral

    Parenteral

    6.3. Global Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19 To 40

    41 To 60

    61 And Over

    6.4. Global Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospital Pharmacies

    Retail Pharmacies And Stores

    Online Pharmacies

    6.5. Global Opioid Use Disorder (OUD) Market, Sub-Segmentation Of Buprenorphine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Suboxone

    Buprenorphine Tablets

    Buprenorphine Film

    6.6. Global Opioid Use Disorder (OUD) Market, Sub-Segmentation Of Naltrexone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Naltrexone Tablets

    Vivitrol

    6.7. Global Opioid Use Disorder (OUD) Market, Sub-Segmentation Of Methadone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Methadone Tablets

    Methadone Oral Solution

    7. Opioid Use Disorder (OUD) Market Regional And Country Analysis

    7.1. Global Opioid Use Disorder (OUD) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Opioid Use Disorder (OUD) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Opioid Use Disorder (OUD) Market

    8.1. Asia-Pacific Opioid Use Disorder (OUD) Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Opioid Use Disorder (OUD) Market

    9.1. China Opioid Use Disorder (OUD) Market Overview

    9.2. China Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Opioid Use Disorder (OUD) Market

    10.1. India Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Opioid Use Disorder (OUD) Market

    11.1. Japan Opioid Use Disorder (OUD) Market Overview

    11.2. Japan Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Opioid Use Disorder (OUD) Market

    12.1. Australia Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Opioid Use Disorder (OUD) Market

    13.1. Indonesia Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Opioid Use Disorder (OUD) Market

    14.1. South Korea Opioid Use Disorder (OUD) Market Overview

    14.2. South Korea Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Opioid Use Disorder (OUD) Market

    15.1. Western Europe Opioid Use Disorder (OUD) Market Overview

    15.2. Western Europe Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Opioid Use Disorder (OUD) Market

    16.1. UK Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Opioid Use Disorder (OUD) Market

    17.1. Germany Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Opioid Use Disorder (OUD) Market

    18.1. France Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Opioid Use Disorder (OUD) Market

    19.1. Italy Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Opioid Use Disorder (OUD) Market

    20.1. Spain Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Opioid Use Disorder (OUD) Market

    21.1. Eastern Europe Opioid Use Disorder (OUD) Market Overview

    21.2. Eastern Europe Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Opioid Use Disorder (OUD) Market

    22.1. Russia Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Opioid Use Disorder (OUD) Market

    23.1. North America Opioid Use Disorder (OUD) Market Overview

    23.2. North America Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Opioid Use Disorder (OUD) Market

    24.1. USA Opioid Use Disorder (OUD) Market Overview

    24.2. USA Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Opioid Use Disorder (OUD) Market

    25.1. Canada Opioid Use Disorder (OUD) Market Overview

    25.2. Canada Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Opioid Use Disorder (OUD) Market

    26.1. South America Opioid Use Disorder (OUD) Market Overview

    26.2. South America Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Opioid Use Disorder (OUD) Market

    27.1. Brazil Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Opioid Use Disorder (OUD) Market

    28.1. Middle East Opioid Use Disorder (OUD) Market Overview

    28.2. Middle East Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Opioid Use Disorder (OUD) Market

    29.1. Africa Opioid Use Disorder (OUD) Market Overview

    29.2. Africa Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Opioid Use Disorder (OUD) Market Competitive Landscape And Company Profiles

    30.1. Opioid Use Disorder (OUD) Market Competitive Landscape

    30.2. Opioid Use Disorder (OUD) Market Company Profiles

    30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Chiesi Pharmaceuticals S.p.A. Overview, Products and Services, Strategy and Financial Analysis

    31. Opioid Use Disorder (OUD) Market Other Major And Innovative Companies

    31.1. Hikma Pharmaceuticals Plc.

    31.2. Mallinckrodt Pharmaceuticals

    31.3. Indivior Plc.

    31.4. Purdue Pharma L.P

    31.5. Alkermes Inc.

    31.6. Collegium Pharmaceutical Inc.

    31.7. Vanda Pharmaceuticals Inc.

    31.8. Camurus AB

    31.9. Tris Pharma Inc.

    31.10. Mylan NV.

    31.11. Orexo US Inc.

    31.12. Zogenix Inc.

    31.13. Rhodes Pharmaceuticals L.P.

    31.14. Omeros Corporation

    31.15. Braeburn Pharmaceuticals Inc.

    32. Global Opioid Use Disorder (OUD) Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Opioid Use Disorder (OUD) Market

    34. Recent Developments In The Opioid Use Disorder (OUD) Market

    35. Opioid Use Disorder (OUD) Market High Potential Countries, Segments and Strategies

    35.1 Opioid Use Disorder (OUD) Market In 2029 - Countries Offering Most New Opportunities

    35.2 Opioid Use Disorder (OUD) Market In 2029 - Segments Offering Most New Opportunities

    35.3 Opioid Use Disorder (OUD) Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Opioid Use Disorder (OUD) Market, Sub-Segmentation Of Buprenorphine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Opioid Use Disorder (OUD) Market, Sub-Segmentation Of Naltrexone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Opioid Use Disorder (OUD) Market, Sub-Segmentation Of Methadone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Opioid Use Disorder (OUD) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Opioid Use Disorder (OUD) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Pfizer Inc. Financial Performance
  • Table 79: Novartis AG Financial Performance
  • Table 80: Viatris Inc. Financial Performance
  • Table 81: Teva Pharmaceutical Industries Ltd. Financial Performance
  • Table 82: Chiesi Pharmaceuticals S.p.A. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Opioid Use Disorder (OUD) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Opioid Use Disorder (OUD) Market, Sub-Segmentation Of Buprenorphine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Opioid Use Disorder (OUD) Market, Sub-Segmentation Of Naltrexone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Opioid Use Disorder (OUD) Market, Sub-Segmentation Of Methadone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Opioid Use Disorder (OUD) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Opioid Use Disorder (OUD) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Pfizer Inc. Financial Performance
  • Figure 79: Novartis AG Financial Performance
  • Figure 80: Viatris Inc. Financial Performance
  • Figure 81: Teva Pharmaceutical Industries Ltd. Financial Performance
  • Figure 82: Chiesi Pharmaceuticals S.p.A. Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the Opioid Use Disorder (OUD) market?

Opioid use disorder (OUD) is a chronic brain disease resulting from prolonged use of opioids, including both prescription painkillers and illegal opioids. Opioid use disorder can develop due to genetic, environmental, and behavioral factors. For further insights on the Opioid Use Disorder (OUD) market, request a sample here

How will the Opioid Use Disorder (OUD) market drivers and restraints affect the market dynamics? What forces will shape the Opioid Use Disorder (OUD) industry going forward?

The Opioid Use Disorder (OUD) market major growth driver - Growing Number Of Opioid Addiction Cases. For further insights on the Opioid Use Disorder (OUD) market, request a sample here

What is the forecast market size or the forecast market value of the Opioid Use Disorder (OUD) market?

The Opioid Use Disorder (OUD) market size has grown strongly in recent years. The opioid use disorder (OUD) market size has grown rapidly in recent years. It will grow from $3.96 billion in 2024 to $4.39 billion in 2025 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to increased prescription rates, pain management practices, drug marketing, stigmatization of addiction The opioid use disorder (OUD) market size is expected to see rapid growth in the next few years. It will grow to $6.94 billion in 2029 at a compound annual growth rate (CAGR) of 12.1%. The growth in the forecast period can be attributed to regulatory interventions, focus on alternative pain management, expansion of treatment access, public health initiatives, . Major trends in the forecast period include technological innovations in treatment, individualized treatment approaches, integrated care models, community-based support programs, early intervention and prevention. For further insights on the Opioid Use Disorder (OUD) market, request a sample here

How is the Opioid Use Disorder (OUD) market segmented?

The opioid use disorder (OUD) market covered in this report is segmented –
1) By Drug Type: Buprenorphine, Naltrexone, Methadone
2) By Route of Administration: Oral, Parenteral
3) By Age Group: 19 To 40, 41 To 60, 61 And Over
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Stores, Online Pharmacies Subsegments:
1) By Buprenorphine: Suboxone, Buprenorphine Tablets, Buprenorphine Film
2) By Naltrexone: Naltrexone Tablets, Vivitrol
3) By Methadone: Methadone Tablets, Methadone Oral Solution For further insights on the Opioid Use Disorder (OUD) market,
request a sample here

Which region has the largest share of the Opioid Use Disorder (OUD) market? What are the other regions covered in the report?

North America was the largest region in the opioid use disorder (OUD) market in 2024. The regions covered in the opioid use disorder (OUD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the Opioid Use Disorder (OUD) market, request a sample here.

Who are the major players in the Opioid Use Disorder (OUD) market?

Major companies operating in the opioid use disorder (OUD) market include Pfizer Inc., Novartis AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Chiesi Pharmaceuticals S.p.A., Hikma Pharmaceuticals Plc., Mallinckrodt Pharmaceuticals, Indivior Plc., Purdue Pharma L.P, Alkermes Inc., Collegium Pharmaceutical Inc., Vanda Pharmaceuticals Inc., Camurus AB, Tris Pharma Inc., Mylan NV., Orexo US Inc., Zogenix Inc., Rhodes Pharmaceuticals L.P., Omeros Corporation, Braeburn Pharmaceuticals Inc., Adapt Pharma Inc., Titan Pharmaceuticals Inc., BioDelivery Sciences International Inc., AcelRx Pharmaceuticals Inc., KemPharm Inc. . For further insights on the Opioid Use Disorder (OUD) market, request a sample here.

What are the key trends in the Opioid Use Disorder (OUD) market?

Major trends in the Opioid Use Disorder (OUD) market include FDA Approval Of Brixadi Marks A Milestone In Opioid Use Disorder (OUD) Market Through Innovative Treatment Options. For further insights on the Opioid Use Disorder (OUD) market, request a sample here.

What are the major opportunities in the Opioid Use Disorder (OUD) market? What are the strategies for the Opioid Use Disorder (OUD) market?

For detailed insights on the major opportunities and strategies in the Opioid Use Disorder (OUD) market, request a sample here.

How does the Opioid Use Disorder (OUD) market relate to the overall economy and other similar markets?

For detailed insights on Opioid Use Disorder (OUD)'s relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Opioid Use Disorder (OUD) industry?

For detailed insights on the mergers and acquisitions in the Opioid Use Disorder (OUD) industry, request a sample here.

What are the key dynamics influencing the Opioid Use Disorder (OUD) market growth? SWOT analysis of the Opioid Use Disorder (OUD) market.

For detailed insights on the key dynamics influencing the Opioid Use Disorder (OUD) market growth and SWOT analysis of the Opioid Use Disorder (OUD) industry, request a sample here.